Brevan Howard Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 56,644 shares of BCRX stock, worth $452,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,644
Previous 79,468
28.72%
Holding current value
$452,019
Previous $603,000
29.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$175 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$159 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$94.7 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$72.5 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$65 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.48B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...